Ascendis Pharma A/S Announces Participation in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
COPENHAGEN, Denmark, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that ... Read More
Ascendis Pharma A/S Reports Third Quarter 2017 Financial Results
- Phase 3 Program for TransCon Growth Hormone Advances and TransCon PTH Enters the Clinic - - Conference Call Today at 4:3... Read More